Max-Planck-Straße 3
Berlin 12489
Germany
49 30 308 380 0
https://www.magforce.de/
Settore/i:
Settore:
Impiegati a tempo pieno: 33
Nome | Titolo | Retribuzione | Esercitate | Anno di nascita |
---|---|---|---|---|
Dr. Benjamin J. Lipps | Chairman of the Management Board & CEO | N/D | N/D | 1940 |
Mr. Christian Von Volkmann M.B.A. | CFO & Member of Management Board | N/D | N/D | 1971 |
Dr. Andreas Jordan | Executive VP, Chief Scientific Officer & MD of Europe | N/D | N/D | 1959 |
Ms. Barbara Von Frankenberg | Vice President of Communications & Investor Relations | N/D | N/D | N/D |
Ms. Solveig Salomon | VP of Marketing & Sales and European Commercial Director | N/D | N/D | N/D |
MagForce AG develops advanced nanomedicine for cancer therapies. It offers NanoTherm therapy system, a combination of medical devices for the treatment of solid brain tumors; NanoPlan, a software that stimulates the temperature distribution in the treatment area; NanoTherm, a magnetic ferrofluid; and NanoActivator, a magnetic field generator. MagForce AG was founded in 1997 and is headquartered in Berlin, Germany.
L'ISS Governance QualityScore di MagForce AG al N/D è N/D. I criteri di valutazione fondamentali sono revisione: N/D; Consiglio di Amministrazione: N/D; diritti degli azionisti: N/D; retribuzione: N/D.